Rosetta Genomics (ROSGQ) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartShort InterestBuy This Stock Rosetta Genomics Short Interest DataRosetta Genomics (ROSGQ) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1,306 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.01Short Interest Ratio0.0 Days to CoverLast Record DateAugust 15, 2025Today's Trading Volume0 sharesAverage Trading Volume1,306 sharesToday's Volume Vs. Average0% Short Selling Rosetta Genomics? Sign up to receive the latest short interest report for Rosetta Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartROSGQ Short Interest Over TimeROSGQ Days to Cover Over TimeROSGQ Percentage of Float Shorted Over Time Rosetta Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025100 shares $0.01 No ChangeN/A0 $0.00 7/31/2025100 shares $0.01 No ChangeN/A0 $0.00 7/15/2025100 shares $0.00 No ChangeN/A1 $0.00 6/30/2025100 shares $0.00 No ChangeN/A0.3 $0.00 6/15/2025100 shares $0.00 No ChangeN/A0 $0.00 5/31/2025100 shares $0.00 No ChangeN/A0 $0.00 5/15/2025100 shares $0.00 No ChangeN/A1 $0.00 4/30/2025100 shares $0.00 No ChangeN/A1 $0.00 4/15/2025100 shares $0.00 No ChangeN/A0 $0.00 3/31/2025100 shares $0.00 No ChangeN/A1 $0.00 Get the Latest News and Ratings for ROSGQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rosetta Genomics and its competitors with MarketBeat's FREE daily newsletter. 3/15/2025100 shares $0.01 No ChangeN/A0 $0.00 2/28/2025100 shares $0.00 No ChangeN/A0 $0.00 2/15/2025100 shares $0.00 No ChangeN/A0 $0.00 1/31/2025100 shares $0.00 No ChangeN/A0.1 $0.00 1/15/2025100 shares $0.00 No ChangeN/A0 $0.00 12/31/2024100 shares $0.00 No ChangeN/A0 $0.00 12/15/2024100 shares $0.00 No ChangeN/A0 $0.00 11/30/2024100 shares $0.00 No ChangeN/A0 $0.00 11/15/2024100 shares $0.00 No ChangeN/A0 $0.00 10/31/2024100 shares $0.00 No ChangeN/A1 $0.00 10/15/2024100 shares $0.00 No ChangeN/A0 $0.00 9/30/2024100 shares $0.00 No ChangeN/A1 $0.00 9/15/2024100 shares $0.00 No ChangeN/A0 $0.00 8/31/2024100 shares $0.00 No ChangeN/A1 $0.00 8/15/2024100 shares $0.00 No ChangeN/A0 $0.00 7/31/2024100 shares $0.00 No ChangeN/A0 $0.00 7/15/2024100 shares $0.00 No ChangeN/A0 $0.00 6/30/2024100 shares $0.00 No ChangeN/A0 $0.00 6/15/2024100 shares $0.00 No ChangeN/A0 $0.00 5/31/2024100 shares $0.00 No ChangeN/A0 $0.00 5/15/2024100 shares $0.00 No ChangeN/A0 $0.00 4/30/2024100 shares $0.00 No ChangeN/A0 $0.00 4/15/2024100 shares $0.00 No ChangeN/A0 $0.00 3/31/2024100 shares $0.00 No ChangeN/A0 $0.00 3/15/2024100 shares $0.00 No ChangeN/A1 $0.00 2/29/2024100 shares $0.00 No ChangeN/A0 $0.00 2/15/2024100 shares $0.00 No ChangeN/A0.1 $0.00 1/15/2024100 shares $0.00 No ChangeN/A0 $0.00 12/31/2023100 shares $0.00 No ChangeN/A0 $0.00 12/15/2023100 shares $0.00 No ChangeN/A1 $0.00Why Trump’s “Smart Dollar” could rewrite the rules (Ad)MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.Get the three steps to take this month to put yourself on the right side of this $30 trillion money 11/30/2023100 shares $0.00 No ChangeN/A0 $0.00 11/15/2023100 shares $0.00 No ChangeN/A0.3 $0.00 10/31/2023100 shares $0.00 No ChangeN/A0.3 $0.00 10/15/2023100 shares $0.00 No ChangeN/A1 $0.00 9/30/2023100 shares $0.00 No ChangeN/A1 $0.00 9/15/2023100 shares $0.01 No ChangeN/A0 $0.00 8/31/2023100 shares $0.00 No ChangeN/A0.2 $0.00 8/15/2023100 shares $0.00 No ChangeN/A1 $0.00 7/31/2023100 shares $0.01 No ChangeN/A0.1 $0.00 7/15/2023100 shares $0.00 No ChangeN/A0.1 $0.00 6/30/2023100 shares $0.00 No ChangeN/A1 $0.00 6/15/2023100 shares $0.00 No ChangeN/A1 $0.00 5/31/2023100 shares $0.00 No ChangeN/A0.3 $0.00 5/15/2023100 shares $0.00 No ChangeN/A0.3 $0.00 4/30/2023100 shares $0.00 No ChangeN/A0.1 $0.00 4/15/2023100 shares $0.00 No ChangeN/A1 $0.00 3/31/2023100 shares $0.00 No ChangeN/A0.5 $0.00 3/15/2023100 shares $0.00 No ChangeN/A1 $0.00 2/28/2023100 shares $0.00 No ChangeN/A0.1 $0.00 2/15/2023100 shares $0.00 No ChangeN/A0.2 $0.00 1/31/2023100 shares $0.00 No ChangeN/A1 $0.00 1/15/2023100 shares $0.00 No ChangeN/A0.5 $0.00 12/30/2022100 shares $0.00 No ChangeN/A0.2 $0.00 12/15/2022100 shares $0.01 No ChangeN/A0.1 $0.00 11/30/2022100 shares $0.00 No ChangeN/A0 $0.00 11/15/2022100 shares $0.00 No ChangeN/A0 $0.00 10/31/2022100 shares $0.00 No ChangeN/A0.3 $0.00 10/15/2022100 shares $0.00 No ChangeN/A1 $0.00 9/30/2022100 shares $0.00 No ChangeN/A0 $0.00 9/15/2022100 shares $0.00 No ChangeN/A0.5 $0.00 8/31/2022100 shares $0.00 No ChangeN/A1 $0.00 8/15/2022100 shares $0.02 No ChangeN/A0.3 $0.00 7/31/2022100 shares $0.02 No ChangeN/A1 $0.00 7/15/2022100 shares $0.02 No ChangeN/A1 $0.00 6/30/2022100 shares $0.02 No ChangeN/A1 $0.00 6/15/2022100 shares $0.02 No ChangeN/A1 $0.00 5/31/2022100 shares $0.02 No ChangeN/A0 $0.00 5/15/2022100 shares $0.03 No ChangeN/A0.3 $0.00 4/30/2022100 shares $0.00 No ChangeN/A1 $0.00 4/15/2022100 shares $0.00 No ChangeN/A1 $0.00 3/31/2022100 shares $0.01 No ChangeN/A1 $0.00 3/15/2022100 shares $0.01 No ChangeN/A0 $0.00 2/28/2022100 shares $0.01 No ChangeN/A0 $0.00 2/15/2022100 shares $0.02 No ChangeN/A0.3 $0.00 1/31/2022100 shares $0.10 No ChangeN/A0.3 $0.00 1/15/2022100 shares $0.00 No ChangeN/A0.1 $0.00 12/31/2021100 shares $0.01 No ChangeN/A0 $0.00 12/15/2021100 shares $0.00 No ChangeN/A0 $0.00 11/30/2021100 shares $0.16 No ChangeN/A0.1 $0.00 11/15/2021100 shares $0.13 No ChangeN/A0 $0.00Why Trump’s “Smart Dollar” could rewrite the rules (Ad)MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.Get the three steps to take this month to put yourself on the right side of this $30 trillion money 10/29/2021100 shares $0.06 -97.8%N/A0 $0.00 10/15/20214,600 shares $1.38 No ChangeN/A1.5 $0.00 9/30/20214,600 shares $46.00 -16.4%N/A1.1 $0.01 9/15/20215,500 shares $192.50 -14.1%N/A0.2 $0.04 8/31/20216,400 shares $192.00 +2,033.3%N/A0.2 $0.03 8/13/2021300 shares $12.75 +200.0%N/A0 $0.04 7/30/2021100 shares $2.45 -99.0%N/A0 $0.02 7/15/20219,500 shares $313.50 +9,400.0%N/A0.4 $0.03 6/30/2021100 shares $6.80 No ChangeN/A0 $0.07 6/15/2021100 shares $4.65 -66.7%N/A0 $0.05 5/28/2021300 shares $18.00 +50.0%N/A0 $0.06 5/14/2021200 shares $13.00 -71.4%N/A0 $0.07 4/30/2021700 shares $61.25 +600.0%N/A0.1 $0.09 4/15/2021100 shares $8.50 -90.9%N/A0 $0.09 3/31/20211,100 shares $88.00 -8.3%N/A0 $0.08 3/15/20211,200 shares $146.40 -90.2%N/A0 $0.12 2/26/202112,300 shares $1.47 thousand +119.6%N/A0.2 $0.12 2/12/20215,600 shares $722.40 +5,500.0%N/A0 $0.13 1/29/2021100 shares $28.00 -99.0%N/A0 $0.28 1/15/202110,500 shares $840.00 +10,400.0%N/A0.3 $0.08 12/31/202014,000 shares $280.00 +33.3%N/A0.2 $0.02 12/15/202010,500 shares $252.00 +10,400.0%N/A0.3 $0.02 11/30/2020100 shares $0.88 No ChangeN/A0 $0.01 11/15/2020100 shares $0.80 No ChangeN/A0 $0.01 10/30/2020100 shares $0.61 No ChangeN/A0 $0.01 10/15/2020100 shares $0.00 -97.2%N/A0 $0.00 ROSGQ Short Interest - Frequently Asked Questions What is Rosetta Genomics' current short interest? Short interest is the volume of Rosetta Genomics shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 100 shares of ROSGQ short. Learn More on Rosetta Genomics' current short interest. How does Rosetta Genomics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rosetta Genomics: Amer Prem Water (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Rosetta Genomics stock? Short selling ROSGQ is an investing strategy that aims to generate trading profit from Rosetta Genomics as its price is falling. ROSGQ shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rosetta Genomics? A short squeeze for Rosetta Genomics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ROSGQ, which in turn drives the price of the stock up even further. How often is Rosetta Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROSGQ, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies 4Front Ventures Short Interest Data Algernon Pharmaceuticals Short Interest Data Allstar Health Brands Short Interest Data Alvotech Short Interest Data Amer Prem Water Short Interest Data American Bio Medica Short Interest Data American Oriental Bioengineering Short Interest Data Anthera Pharmaceuticals Short Interest Data AstraZeneca Short Interest Data AVVAA World Health Care Products Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ROSGQ) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rosetta Genomics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rosetta Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROSGQ Stock Alerts